title: No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
abstract: Methylenetetrahydrofolate reductase (MTHFR) is an enzyme (EC 1.5.1.20), that reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a carbon donor for the homocysteine to methionine conversion. MTHFR is a key enzyme that regulates folate metabolism which has an important role in DNA synthesis, DNA repair and methylation. The association between MTHFR C677T polymorphism and breast cancer has been investigated in several previous studies. Some researchers have shown an association between C677T polymorphism and breast cancer, but not all researchers found this association however. This study was designed to investigate, in the Turkish population, the association of MTHFR C677T polymorphism and breast cancer. Forty women patients with breast cancer and 68 healthy women were included in the study. MTHFR gene polymorphism was determined by the PCR-RFLP method. SPSS 10.0 for windows was used to determine statistical significance. No differences were observed in the distribution of MTHFR genotypes or allele frequencies in the cases versus the controls. It was found that the frequencies of MTHFR polymorphism were 55%, 40%, 5% for CC, CT, TT genotype in patients and 56%, 38%, 6% in healthy controls respectively. Furthermore, association was observed among family history, metastatic risk and MTHFR genotypes in patients. Our data fail to support a relationship between MTHFR C677T and the risk for breast cancer. It may be that there are ethnic differences in terms of this relationship.
authors.affiliation: Dr Pakize I Tarzi Laboratories, Istanbul, Turkey.
authors.forename: Nezih
authors.initials: N
authors.lastname: Hekim
authors.forename: Arzu
authors.initials: A
authors.lastname: Ergen
authors.forename: Ilhan
authors.initials: I
authors.lastname: Yaylim
authors.forename: Hülya
authors.initials: H
authors.lastname: Yilmaz
authors.forename: Umit
authors.initials: U
authors.lastname: Zeybek
authors.forename: Oğuz
authors.initials: O
authors.lastname: Oztürk
authors.forename: Turgay
authors.initials: T
authors.lastname: Isbir
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics*; D003545:Cysteine / Q000235:genetics / Q000378:metabolism; D005260:Female; D005838:Genotype; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic / Q000235:genetics*; D012307:Risk Factors
chemical_list: D042965:Methylenetetrahydrofolate Reductase (NADPH2); D003545:Cysteine